NEW YORK (360Dx) – Grifols today announced CE marking for its ID RHD XT diagnostic test for RHD genotyping.

The kit, the firm said, is designed to be used on the same platform as its ID Core XT and ID HPA XT molecular typing solutions. The reliability, speed, and accuracy of the new test also matches those of ID Core XT and ID HPA XT, and enables immunochematologists to obtain results within four hours of DNA extraction.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.